The EBITDA margin stood at 25.7% in the third quarter versus 23.3% in the year-ago period. Shares of Mankind Pharma Ltd ended at ₹2,610, up by ₹94.95, or 3.78%, on the BSE.
Share it
Related Article
Open an Account in less than 1 Min.
Need help? Call us
+91 888 718 7394
Services
Company
Get in touch
- +91 888 718 7394
- info@markettrade.live
- Pjazza Mifsud Bonnici, Marsascala, Malta
- 333, Pali Pathar, Khar West, Mumbai, Maharashtra 400052
Copyright © 2025 Market Trade